Adcirca, a new formulation of tadalafil (Cialis) for treating pulmonary arterial hypertension

Please see the August 2012 FDA warning concerning the use of Revatio in children with PAH

You'll see Adcirca, a new formulation of tadalafil (Cialis) for treating pulmonary arterial hypertension.

It will be used as an alternative to Revatio (sildenafil).

Both Adcirca and Revatio can help improve exercise tolerance in these patients by lowering blood pressure in the lungs.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote